In this study, while our findings establish TFPI2 as the central mediator of polydatin chemosensitization effects in HCC, we acknowledge that the inherent polypharmacology of natural compounds necessitates rigorous off-target profiling. Here, TFPI2 is linked to hepatocellular carcinoma.